Press "Enter" to skip to content

Vertex Pharmaceuticals expands into Duchenne gene therapy with new deals

Vertex Pharmaceuticals Inc said on Thursday it would acquire privately held Exonics Therapeutics for an upfront payment of $245 million and potential milestone payments of up to $750 million.

Original source:

Also Read:   French coronavirus 24-hour death toll under 30 for fourth day